Mifepristone improves octreotide efficacy in resistant ectopic Cushing’s syndrome.
Moraitis AG, Auchus RJ. • 2016 • Case Rep Endocrinol. 2016;2016:8453801.
© 2024 Corcept Therapeutics, Incorporated
New selective glucocorticoid receptor modulators reverse amyloid-β peptide-induced hippocampus toxicity.
Pineau et al. • 2016 • Neurobiol Aging. 2016;45:109-122.
Prevalence of hypercortisolism in type 2 diabetes patients: a systematic review and meta-analysis
Steffensen et al • 2016 • European Journal of Endocrinology